Dynamic Radiotherapy Strategy Adjustment via Real-Time Risk Modeling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current radiotherapy-based treatments face challenges in accurately quantifying and managing the risk of adverse events, which affects the balance between treatment efficacy and patient safety, particularly in combination therapies like radiotherapy and immunotherapy.

Innovation Solution

A computer-implemented method that generates a radiotherapy-based treatment strategy by obtaining and modifying a risk value based on identified side-effects, using temporal and severity characteristics to adjust the treatment plan and minimize risk while maximizing efficacy, employing a risk model to classify subjects and update treatment strategies iteratively.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If radiation dose is increased to improve treatment efficacy, then tumor size reduction is improved, but risk of adverse events increases

Engineering Contradiction:
Improvetumor size reductionVSAvoidadverse events risk
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

The patent dynamically adjusts treatment parameters (radiation dose, fractionation scheme) based on real-time monitoring of adverse events and tumor response. The risk value model allows continuous modification of treatment parameters to optimize the balance between efficacy and safety throughout the treatment course.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The system implements continuous feedback loops where adverse events are monitored, risk values are updated, and treatment plans are adjusted accordingly. This closed-loop control enables real-time optimization of radiation dosing based on actual patient response and tolerance.

Inventive Principle:
Principle #23Feedback

2Object-affected harmful factors

If treatment characteristics are adjusted to reduce risk, then adverse events are reduced, but treatment efficacy decreases

Engineering Contradiction:
Improveadverse events riskVSAvoidtumor size reduction
Core Design Contradiction:
Object-affected harmful factorsVSManufacturing precision

Solution Approach 1:

The treatment plan transitions from static to dynamic, with continuous adjustment of radiation dose and scheduling based on real-time patient response. The system adapts treatment characteristics dynamically to maintain optimal efficacy while minimizing risk throughout the treatment course.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

Treatment parameters such as radiation dose, fractionation, and scheduling are continuously modified based on updated risk values. This allows the system to reduce risk while preserving efficacy by optimizing parameters rather than simply lowering overall dose.

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If a fixed treatment plan is used, then treatment simplicity is maintained, but ability to respond to adverse events is reduced

Engineering Contradiction:
Improvetreatment plan simplicityVSAvoidresponse to adverse events
Core Design Contradiction:
Ease of operationVSAdaptability or versatility

Solution Approach 1:

The system pre-establishes risk models, monitoring protocols, and adjustment algorithms before treatment begins. This preliminary preparation enables rapid, automated responses to adverse events without requiring complex real-time decision-making, maintaining operational simplicity while enhancing adaptability.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The treatment planning system automatically adjusts treatment parameters based on monitored adverse events and updated risk values, reducing the need for manual intervention. The system serves itself by continuously optimizing treatment based on real-time data without requiring constant clinician input.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS11389667B2Methods and apparatus for reducing risk to a subject undergoing radiotherapy-based treatment
Publication Date: 2022.07.19 ELEKTA AB
  • US11389667B2 patent drawing
  • US11389667B2 patent drawing
  • US11389667B2 patent drawing

AI summary

A method of generating a strategy for performing a radiotherapy-based treatment and a system for performing the method. During a radiotherapy-based treatment, characteristics of side-effects are monitored and a risk model of the subject modified based on the characteristics. A new treatment strategy for the radiotherapy-based treatment is obtained based on the modified risk model.